Report on the review and arrangements on the supply of drugs and medicines.

Hdl Handle:
http://hdl.handle.net/10147/575465
Title:
Report on the review and arrangements on the supply of drugs and medicines.
Authors:
Department of Health (DoH); Trident Management Consultants for the Department of Health (DOH)
Citation:
Department of Health. 1980. Report on the review and arrangements on the supply of drugs and medicines. Dublin: Stationery Office.
Publisher:
Department of Health (DoH)
Issue Date:
Dec-1980
URI:
http://hdl.handle.net/10147/575465
Item Type:
Report
Language:
en
Description:
The costs of drugs (including medicines) under the health services have risen significantly since 1972. These increases have not been confined to anyone sector of the health service but apply to all aspects of hospitals and the GMS' scheme. The rises are partly explained by greater eligibility and higher prescribing rates, but are also caused by inflation in prices, higher volume usage and the introduction of new and more expensive drugs. Table 1.1 below shows a comparison of the costs of drugs in 1973 with the estimated costs for 1979.
Keywords:
HEALTH SERVICES AND THEIR MANAGEMENT; DRUG; MEDICINE; PRESCRIPTION

Full metadata record

DC FieldValue Language
dc.contributor.authorDepartment of Health (DoH)en_GB
dc.contributor.authorTrident Management Consultants for the Department of Health (DOH)en_GB
dc.date.accessioned2015-08-21T15:56:00Zen
dc.date.available2015-08-21T15:56:00Zen
dc.date.issued1980-12-
dc.identifier.citationDepartment of Health. 1980. Report on the review and arrangements on the supply of drugs and medicines. Dublin: Stationery Office.en_GB
dc.identifier.urihttp://hdl.handle.net/10147/575465en
dc.descriptionThe costs of drugs (including medicines) under the health services have risen significantly since 1972. These increases have not been confined to anyone sector of the health service but apply to all aspects of hospitals and the GMS' scheme. The rises are partly explained by greater eligibility and higher prescribing rates, but are also caused by inflation in prices, higher volume usage and the introduction of new and more expensive drugs. Table 1.1 below shows a comparison of the costs of drugs in 1973 with the estimated costs for 1979.en_GB
dc.language.isoenen
dc.publisherDepartment of Health (DoH)en_GB
dc.subjectHEALTH SERVICES AND THEIR MANAGEMENTen_GB
dc.subjectDRUGen_GB
dc.subjectMEDICINEen_GB
dc.subjectPRESCRIPTIONen_GB
dc.titleReport on the review and arrangements on the supply of drugs and medicines.en_GB
dc.typeReporten
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.